期刊文献+

EHV-1_(CN)与IL-2基因共表达核酸疫苗诱导产生CTL的观察 被引量:2

Cytotoxic T Lymphocyte Induced with DNA Vaccine Prepared by Co-expression of HIV-1_(CN) gp 120 and IL-2 Genes
暂未订购
导出
摘要 目的 观察HIV-1CN gp120基因与IL-2基因共表达核酸疫苗质粒pGPIL-2诱导产生CTL。方法 脂质体介导共表达中国流行株HIV-1Gag-gp120基因与IL-2基因的核酸疫苗质粒pGIL-2转染BHK-21细 胞,以间接免疫光法鉴定其表达。取pGPIL-2免疫鼠脾细胞,检测pGPIL-2诱导的细胞毒性T细胞杀伤活性。 结果pGPIL-2可有效地诱导CIL的产生,并可杀伤HIV-1CN嵌合基因转染的靶细胞。结论 为进一步设计中国流行株HIV-1核酸疫苗提供了重要实验依据。 Objective To observe the cytotoxic T lymphocyte(CTL)induced with the DNA vaccine prepared by the co-expression of HIV-1CN gp 120 and IL-2 genes. Methods The plasmid pGPIL-2 for the coexpression of HW-1 Gag-gp 120 and IL-2 genes was transfected to BHK-21 cells under the mediation of liposome, and the expressed product was identified by indirect immumofluorescence method. Murine splenocytes were immunized with the pGPIL-2, and the CFL killing activity of the mice was detected. Results The CTL killing activity to the target cells transfected with HIV-1CN chimeric gene was effectively induced by pCPIL-2. Conclusion The study provides an important basis for further developing the DNA vaccine against the current HIV-1 strain in China.
出处 《中国生物制品学杂志》 CAS CSCD 2001年第2期81-83,共3页 Chinese Journal of Biologicals
基金 国家自然科学基金(3977066) 国家杰出青年基(39825119)资助
  • 相关文献

参考文献3

  • 1Kim J J,J Interferon Cytokine Res,1999年,19卷,1期,77页
  • 2Sin K Q,Vaccine,1999年,17卷,858页
  • 3金冬雁(译),分子克隆实验指南,1993年,16页

同被引文献14

  • 1[1]Krug LM,Grant SC,Miller VA,et al.Strategies to eradicate minimal residual disease in cell lung cancer:high-dose chemotherapy with autologous bone marrow transplantation,matrix metalloproteinase inhibitors,andBEC2 plus BCG vaccination. Semin Oncol,1999,26:55~61
  • 2[2]Kozlowski J.This month in investigative urology:Immunotherapy of bladder cancer.J.Urol,1999 .162(5):1806~1811
  • 3[3]Agarwala SS,Kirkwood JM.Adjuvant therapy of melamona.Semin Surg Oncol,1998,14:302~310
  • 4[4]Goebel FD,Mannhalter JW,Belshe RB,et al.Recombiant gp160as a therapeuticvaccine for HIV-infection:result of a large randomized,controlled trial.European Multinational IMMUNO AIDS Vaccine Study Group.AIDS,1999,13:1461~1468
  • 5[5]Amara RR,Villinger F .Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.Science,2001,292:69~74
  • 6[6]Celis E,Chang TS .HbsAg-serum protein complexes stimulate immune T lymphocytes more efficiently than do pure HbsAg.Hepatology,1984,6:.1116~1121
  • 7[7]Ishioka GY,Fikes J,Hermanson G,et al.Utilization of MHC classⅠtransgenicmice for development of minigene DNA vaccines encoding multiple HLA-restrictedCTL epitopes.J Immunol 1999,162(7):3915~3925
  • 8[8]Ayed M,Ben Hassine L,Ben Slama R,et al.Results ofBCG in the treatment ofpTa and pT1 bladder tumors:Evaluation of a long protocol using 75 mg of Pasteurstrain BCG.Prog Urol,1998 ,8:206~210
  • 9[10]Sabbaj S,Mulligan MJ.Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine.AIDS ,2000 ,14 (10):1365~1374
  • 10[11]Pol S,Driss F,Michel ML,et al.Specific vaccine therapy in chronic hepatitis B infection.Lancet,1994 ,344:342.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部